# RA Capital Management's Pharma Investments: 44 Startups in Its Portfolio (2026) > The 44 Pharma startups RA Capital Management has backed, by stage: $8.1B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/ra-capital-management-pharma-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 21 - [Mineralys Therapeutics](https://millionrounds.com/company/mineralys-therapeutics) - [Dianthus Therapeutics](https://millionrounds.com/company/dianthus-therapeutics) - [Vaxcyte](https://millionrounds.com/company/vaxcyte) - [GH Research](https://millionrounds.com/company/gh-research) - [*I* Inhibrx](https://millionrounds.com/company/inhibrx) - [Aurinia Pharmaceuticals](https://millionrounds.com/company/aurinia-pharmaceuticals) - [Edgewise Therapeutics](https://millionrounds.com/company/edgewise-therapeutics) - [Jade Biosciences](https://millionrounds.com/company/jade-biosciences) - [Day One Biopharmaceuticals](https://millionrounds.com/company/day-one-biopharmaceuticals) - [Bicara Therapeutics](https://millionrounds.com/company/bicara-therapeutics) - [Monopar](https://millionrounds.com/company/monopar) - [Point Biopharma](https://millionrounds.com/company/point-biopharma) - [ARS Pharmaceuticals](https://millionrounds.com/company/ars-pharmaceuticals) - [HilleVax](https://millionrounds.com/company/hillevax) - [Interius BioTherapeutics](https://millionrounds.com/company/interius-biotherapeutics) - [Indapta Therapeutics](https://millionrounds.com/company/indapta-therapeutics) - [Xilio Therapeutics](https://millionrounds.com/company/xilio-therapeutics) - [Equillium](https://millionrounds.com/company/equillium) - [ALX Oncology](https://millionrounds.com/company/alx-oncology) - [Seres Therapeutics](https://millionrounds.com/company/seres-therapeutics) - [Palisade Bio](https://millionrounds.com/company/palisade-bio) ## Series B 10 - [Ollin Biosciences](https://millionrounds.com/company/ollin-biosciences) - [Metsera](https://millionrounds.com/company/metsera) - [KalVista Pharmaceuticals](https://millionrounds.com/company/kalvista-pharmaceuticals) - [Diagonal Therapeutics](https://millionrounds.com/company/diagonal-therapeutics) - [Claris Biotherapeutics](https://millionrounds.com/company/claris-biotherapeutics) - [Triana Biomedicines](https://millionrounds.com/company/triana-biomedicines) - [Curevo](https://millionrounds.com/company/curevo) - [Clementia Pharmaceuticals](https://millionrounds.com/company/clementia-pharmaceuticals) - [Pinnacle Medicines](https://millionrounds.com/company/pinnacle-medicines) - [Enara Bio](https://millionrounds.com/company/enara-bio) ## Series C and later 7 - [Parabilis Medicines](https://millionrounds.com/company/parabilis-medicines) - [Ovid Therapeutics](https://millionrounds.com/company/ovid-therapeutics) - [Artios Pharma](https://millionrounds.com/company/artios-pharma) - [Angitia Biopharmaceuticals](https://millionrounds.com/company/angitia-biopharmaceuticals) - [Cyteir Therapeutics](https://millionrounds.com/company/cyteir-therapeutics) - [Be Biopharma](https://millionrounds.com/company/be-biopharma) - [Gameto](https://millionrounds.com/company/gameto) ## Series A 6 - [Korsana Biosciences](https://millionrounds.com/company/korsana-biosciences) - [*AB* Aiolos Bio](https://millionrounds.com/company/aiolos-bio) - [Solstice Oncology](https://millionrounds.com/company/solstice-oncology) - [Stipple Bio](https://millionrounds.com/company/stipple-bio) - [Rampart Bioscience](https://millionrounds.com/company/rampart-bioscience) - [Typewriter Therapeutics](https://millionrounds.com/company/typewriter-therapeutics) ## Segment by segment ### Stage not reported 21 startups · $4.3B raised - [**Mineralys Therapeutics**](https://millionrounds.com/company/mineralys-therapeutics) Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension. United States $788M - [**Dianthus Therapeutics**](https://millionrounds.com/company/dianthus-therapeutics) Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach. United States $719M - [**Vaxcyte**](https://millionrounds.com/company/vaxcyte) Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. United States $633M - [**GH Research**](https://millionrounds.com/company/gh-research) GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness. Ireland $268M - [*I* **Inhibrx**](https://millionrounds.com/company/inhibrx) United States $265M - [**Aurinia Pharmaceuticals**](https://millionrounds.com/company/aurinia-pharmaceuticals) Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases. Canada $255M - [**Edgewise Therapeutics**](https://millionrounds.com/company/edgewise-therapeutics) Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization. United States $200M - [**Jade Biosciences**](https://millionrounds.com/company/jade-biosciences) Jade Biosciences is developing transformative therapies to redefine the standard of care for inflammation and immunology indications. United States $195M ### Series B 10 startups · $1.5B raised - [**Ollin Biosciences**](https://millionrounds.com/company/ollin-biosciences) Ollin Biosciences is a clinical-stage biopharmaceutical company based in Austin, Texas, founded in 2023. United States $430M - [**Metsera**](https://millionrounds.com/company/metsera) Metsera operates as a clinical-stage biopharmaceutical company. United States $215M - [**KalVista Pharmaceuticals**](https://millionrounds.com/company/kalvista-pharmaceuticals) KalVista Pharmaceuticals focuses on developing oral medicines, particularly for managing hereditary angioedema. United States $125M - [**Diagonal Therapeutics**](https://millionrounds.com/company/diagonal-therapeutics) Diagonal Therapeutics is developing a new class of clustering antibody medicines designed to address the root causes of severe gen United States $125M - [**Claris Biotherapeutics**](https://millionrounds.com/company/claris-biotherapeutics) Claris Biotherapeutics is a late-clinical stage biotechnology company based in Jersey City, New Jersey. United States $124M - [**Triana Biomedicines**](https://millionrounds.com/company/triana-biomedicines) TRIANA Biomedicines is a private biopharmaceutical company founded in 2019 and based in Lexington, Massachusetts. United States $120M - [**Curevo**](https://millionrounds.com/company/curevo) Curevo is a clinical-stage biotech firm that focuses on producing vaccines. United States $110M - [**Clementia Pharmaceuticals**](https://millionrounds.com/company/clementia-pharmaceuticals) Clementia is a clinical-stage company innovating treatments for people with ultra-rare bone disorders. Canada $93M ### Series C and later 7 startups · $1.1B raised - [**Parabilis Medicines**](https://millionrounds.com/company/parabilis-medicines) Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines. United States $380M - [**Ovid Therapeutics**](https://millionrounds.com/company/ovid-therapeutics) Ovid Therapeutic's purpose is to solve intractable medical problems. United States $166M - [**Artios Pharma**](https://millionrounds.com/company/artios-pharma) Artios Pharma is a independent DNA Damage Response company with a strong pipeline of novel cancer therapies. United Kingdom $148M - [**Angitia Biopharmaceuticals**](https://millionrounds.com/company/angitia-biopharmaceuticals) Angitia Biopharmaceuticals is a clinical-stage biotechnology company founded in 2018, dedicated to developing innovative therapies United States $130M - [**Cyteir Therapeutics**](https://millionrounds.com/company/cyteir-therapeutics) Cyteir is developing the next generation of synthetic lethal therapies to treat cancer. United States $126M - [**Be Biopharma**](https://millionrounds.com/company/be-biopharma) Be Biopharma, also known as Be Bio, is a clinical-stage biotechnology company based in Cambridge, Massachusetts. United States $92M - [**Gameto**](https://millionrounds.com/company/gameto) Gameto is a biotechnology company founded in 2020, dedicated to advancing women’s reproductive health. United States $44M ### Series A 6 startups · $1.2B raised - [**Korsana Biosciences**](https://millionrounds.com/company/korsana-biosciences) Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s. United States $530M - [*AB* **Aiolos Bio**](https://millionrounds.com/company/aiolos-bio) Aiolos Bio is a biotech company developing innovative therapies for respiratory diseases and immune conditions. United States $245M - [**Solstice Oncology**](https://millionrounds.com/company/solstice-oncology) Solstice Oncology develops immuno-oncology therapies focused on treating and preventing cancer through targeted approaches. United States $225M - [**Stipple Bio**](https://millionrounds.com/company/stipple-bio) Stipple Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2022. United States $100M - [**Rampart Bioscience**](https://millionrounds.com/company/rampart-bioscience) Rampart Bioscience is a private biotechnology company focused on developing non-viral, DNA-based gene medicines for genetically dr United States $85M - [**Typewriter Therapeutics**](https://millionrounds.com/company/typewriter-therapeutics) Typewriter Therapeutics develops mRNA-based gene therapies using a gene writing platform for site-specific insertion of therapeutic genes. United States $56M **How this map is made.** Every startup here works in Pharma and has raised money in a round we track that names RA Capital Management as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **RA Capital Management's Healthtech portfolio** 10 startups · $1.2B](https://millionrounds.com/portfolio-maps/ra-capital-management-healthtech-portfolio)[Portfolio map **RA Capital Management portfolio map** 264 startups · $48B](https://millionrounds.com/portfolio-maps/ra-capital-management-portfolio-map)[Co-investors **Who invests with RA Capital Management** 152 co-investors](https://millionrounds.com/portfolio-maps/ra-capital-management-co-investors)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio) ## Raising from investors like RA Capital Management? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)